SGF29 and cancer: In the COSMIC database (https://cancer.sanger.ac.uk/cosmic), over 10% of tested patient samples of breast, haematological, large intestine and stomach cancers show overexpression of Sgf29 as well as 5 out of 8 cancer cell lines, compared to non-transformed lines (35).